Risk category | Â | Referral | Medication | |
---|---|---|---|---|
 |  | CVD risk screening | Doctor referral |  |
High risk | ≥30% risk | every 3-6 months | Yes | BP lowering therapy |
 | or past CVD history |  |  | Lipid lowering |
 |  |  |  | Antiplatelets |
Intermediate | 20 to <30% risk | every year | Yes | BP lowering therapy |
risk |  |  |  | (if BP ≥ 140/90) |
 |  |  |  | Lipid lowering |
 |  |  |  | (if Diabetes is present |
 |  |  |  | or SBP ≥160 mmHg |
 |  |  |  | or TC>200 mg/dL or |
 |  |  |  | LDL>120 mg/dL) |
 | 10 to <20% risk | every 2 years | Yes if | BP lowering therapy |
 |  |  | (Diabetes or | (if Diabetes is present |
 |  |  | IFG is present) | and BP ≥140/90 |
 |  |  |  | or SBP ≥160 mmHg) |
 |  |  | or | Lipid lowering |
 |  |  | (history of diabetes | (if Diabetes is present |
 |  |  | and SBP ≥160 mmHg) | or SBP ≥160 mmHg) |
Low risk | 0 to <10% risk | every 5 years | Yes if | BP lowering therapy |
 |  |  | (Diabetes or | (if Diabetes is present |
 |  |  | IFG is present) | and BP ≥140/90 |
 |  |  |  | or SBP ≥160 mmHg) |
 |  |  | or | Lipid lowering |
 |  |  | (history of diabetes | (if Diabetes is present |
 |  |  | and SBP ≥160 mmHg) | or SBP ≥160 mmHg) |